* Expects to submit additional data to FDA by Q1 2010
* Says was anticipating similar data request from FDA
Aug 21 (Reuters) - AspenBio Pharma Inc APPY.O said U.S. health regulators have sought additional information on its experimental blood-based test to diagnose appendicitis.
AspenBio Pharma said it believes it will be able to submit the additional data to the U.S. Food and Drug Administration by the first quarter of 2010.
The company said it had anticipated a request from the FDA and had proceeded proactively with certain additional analyses and testing, including supplemental trial work.
Shares of the company closed at about $2.40 Thursday on Nasdaq.
For the alerts double-click [ID:nWNAB2544] . (Reporting by Anand Basu in Bangalore; Editing by Deepak Kannan)